Molecular profiling of pancreatic neuroendocrine tumors in sporadic and von Hippel-Lindau patients

Clinical Cancer Research, 04/04/2012

This study shows that the progression of PanNET in Von Hippel–Lindau (VHL) patients tumors follows a specific pathway and supports that targeting molecules specifically involved may be of therapeutic importance.

Print Article Summary Cat 2 CME Report